Nicola Giuliani

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

Nicola Giuliani, Régis Bataille, Cristina Mancini et al. · Blood · 2001 · 413 citations · Full text

Medicine, Cell Biology, Oncology +15

Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation

Nicola Giuliani, Simona Colla, Francesca Morandi et al. · Blood · 2005 · 317 citations · Full text

Medicine, Cell Biology, Genetics +17

Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network

Antonio Palumbo, Patrizia Falco, Paolo Corradini et al. · Journal of Clinical Oncology · 2007 · 317 citations

Medicine, Pharmacology, Pharmacotherapy +15

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients

Nicola Giuliani, Francesca Morandi, Sara Tagliaferri et al. · Blood · 2007 · 276 citations · Full text

Medicine, Oncology, Pharmacology +16